Amarin Corporation PLC
NASDAQ:AMRN

Watchlist Manager
Amarin Corporation PLC Logo
Amarin Corporation PLC
NASDAQ:AMRN
Watchlist
Price: 14.92 USD -9.79% Market Closed
Market Cap: 310.2m USD

Amarin Corporation PLC
Net Issuance of Common Stock

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Amarin Corporation PLC
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Amarin Corporation PLC
NASDAQ:AMRN
Net Issuance of Common Stock
$57k
CAGR 3-Years
-65%
CAGR 5-Years
-64%
CAGR 10-Years
-50%
Alkermes Plc
NASDAQ:ALKS
Net Issuance of Common Stock
$40.2m
CAGR 3-Years
28%
CAGR 5-Years
32%
CAGR 10-Years
-2%
Prothena Corporation PLC
NASDAQ:PRTA
Net Issuance of Common Stock
-$59k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mural Oncology PLC
NASDAQ:MURA
Net Issuance of Common Stock
$196k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Amarin Corporation PLC
Glance View

Market Cap
310.3m USD
Industry
Biotechnology

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics for cardiovascular disease management. The firm operates through the development and commercialization of Vascepa segment. Its lead product, Vascepa (icosapent ethyl) capsule for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

AMRN Intrinsic Value
HIDDEN
Show

See Also

What is Amarin Corporation PLC's Net Issuance of Common Stock?
Net Issuance of Common Stock
57k USD

Based on the financial report for Sep 30, 2025, Amarin Corporation PLC's Net Issuance of Common Stock amounts to 57k USD.

What is Amarin Corporation PLC's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-50%

Over the last year, the Net Issuance of Common Stock growth was -74%. The average annual Net Issuance of Common Stock growth rates for Amarin Corporation PLC have been -65% over the past three years , -64% over the past five years , and -50% over the past ten years .

Back to Top